Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126066201 | 12606620 | 1 | I | 2015 | 20160719 | 20160729 | 20160729 | EXP | BR-ELI_LILLY_AND_COMPANY-BR201607012059 | ELI LILLY AND CO | 0.00 | M | Y | 65.00000 | KG | 20160728 | CN | BR | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126066201 | 12606620 | 1 | PS | EFFIENT | PRASUGREL HYDROCHLORIDE | 1 | Unknown | 10 MG, QD | U | U | 22307 | 10 | MG | TABLET | QD | ||||
| 126066201 | 12606620 | 2 | SS | EFFIENT | PRASUGREL HYDROCHLORIDE | 1 | Unknown | .5 DF, QD | U | U | 22307 | 5 | MG | TABLET | QD | ||||
| 126066201 | 12606620 | 3 | SS | VASTAREL | TRIMETAZIDINE DIHYDROCHLORIDE | 1 | Unknown | 35 MG, QD | U | U | 0 | 35 | MG | QD | |||||
| 126066201 | 12606620 | 4 | SS | MONOCORDIL | ISOSORBIDE MONONITRATE | 1 | Unknown | 20 MG, TID | U | U | 0 | 20 | MG | TID | |||||
| 126066201 | 12606620 | 5 | SS | ROSUVASTATINA /01588601/ | ROSUVASTATIN | 1 | Unknown | 10 MG, QD | U | U | 0 | 10 | MG | QD | |||||
| 126066201 | 12606620 | 6 | SS | CARVEDILOL. | CARVEDILOL | 1 | Unknown | U | U | 0 | BID | ||||||||
| 126066201 | 12606620 | 7 | SS | PRESSOMEDE | ENALAPRIL MALEATE | 1 | Unknown | UNK UNK, UNKNOWN | U | U | 0 | ||||||||
| 126066201 | 12606620 | 8 | SS | ASPIRINA | ASPIRIN | 1 | Unknown | 100 MG, UNKNOWN | Y | U | 0 | 100 | MG | ||||||
| 126066201 | 12606620 | 9 | C | ASPIRINA | ASPIRIN | 1 | Unknown | 100 MG, UNKNOWN | U | 0 | 100 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126066201 | 12606620 | 1 | Antiplatelet therapy |
| 126066201 | 12606620 | 3 | Product used for unknown indication |
| 126066201 | 12606620 | 4 | Product used for unknown indication |
| 126066201 | 12606620 | 5 | Product used for unknown indication |
| 126066201 | 12606620 | 6 | Product used for unknown indication |
| 126066201 | 12606620 | 7 | Product used for unknown indication |
| 126066201 | 12606620 | 8 | Product used for unknown indication |
| 126066201 | 12606620 | 9 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126066201 | 12606620 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126066201 | 12606620 | Infarction | |
| 126066201 | 12606620 | Intentional product misuse | |
| 126066201 | 12606620 | Pulmonary oedema |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126066201 | 12606620 | 1 | 2014 | 2016 | 0 | |
| 126066201 | 12606620 | 2 | 2016 | 2016 | 0 | |
| 126066201 | 12606620 | 3 | 201509 | 0 | ||
| 126066201 | 12606620 | 4 | 2014 | 0 | ||
| 126066201 | 12606620 | 5 | 201603 | 0 | ||
| 126066201 | 12606620 | 6 | 201601 | 0 | ||
| 126066201 | 12606620 | 7 | 2016 | 0 | ||
| 126066201 | 12606620 | 8 | 201606 | 0 | ||
| 126066201 | 12606620 | 9 | 201606 | 0 |